4-(Tetrahydro-2H-pyran-4-yl)methoxyphenylboronic acid, 98%, 1g

2-Cyano-N,N-diethylacetamide>98.0%(GC)5g

1-Piperidin-1-yl-ethanone, 95.0%, 25g

Molybdenum(VI) oxide, min. 99.8%, pa, 250 g, plastic packaging.

3-Bromopyrazolo[1,5-a]pyrimidin-7-amine, 97%, 1g

(2S,4S)-4-Fluoropyrrolidine-2-carboxamide hydrochloride, 95.0%, 1g

1,2-Bis(dimethylsilyl)benzene, 95%, 25g

(4S,4'S)-1,1',4,4'-Tetraisopropyl-4,4',5,5'-tetrahydro-1H,1'H-2,2'-biimidazole, 97%, 100mg

1,8,10-triazatricyclo[7.4.0.0(2,7)]trideca-2,4,6,8,10,12-hexaen-11-ol, 95.0%, 500mg

1-(Tert-butoxycarbonyl)-4,4-difluoropiperidine-2-carboxylic acid, 95.0%, 5g

4-(tert-Butyl)-3-chlorophenol, 97%, 500mg

(3,5-Dichlorophenyl)(2,4,6-trimethoxyphenyl)iodonium p-Toluenesulfonate>95.0%(HPLC)200mg

Rottlerin, 5mg